The Cancer Letter

Inside information on cancer research and drug development

Drugs & Targets

Stem Cell Theranostics and CapellaBio launch collaboration on cardiotoxicity

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

MD Anderson Cancer Center and Kymab announced a partnership in immuno-oncology research.

The program will be conducted with MD Anderson’s Oncology Research for Biologics and Immunotherapy Translation unit. The partnership will focus on developing novel human therapeutic antibodies to treat a variety of cancers using Kymab’s Kymouse antibody discovery platform. The agreement is for an initial period of five years.

The ORBIT platform is a centralized organization within MD Anderson, which focuses on translating discoveries into clinically relevant anti-cancer mAbs. ORBIT’s scientific directors are Jeffrey Molldrem, professor of the Department of Stem Cell Transplantation and Cellular Therapy, and Michael Curran, professor of the Department of Immunology.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
By Monica L. Baskin, Nadine J. Barrett, Kim F. Rhoads, Hayley S. Thompson, Kimlin Tam Ashing, Folakemi T. Odedina and Vanessa B. Sheppard

Art exhibit at University of Miami Sylvester bridges North and South America

“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.
By Claire Marie Porter
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account